BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

797 related articles for article (PubMed ID: 2124179)

  • 21. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evaluation of the TCu 380Ag and the Multiload Cu375.
    Cole LP; Potts DM; Aranda C; Behlilovic B; Etman ES; Moreno J; Randic L
    Fertil Steril; 1985 Feb; 43(2):214-7. PubMed ID: 3881295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
    Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
    Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twelve-month comparative multicenter study of the TCu 380A and ML 250 intrauterine devices in Bangkok, Thailand.
    Reinprayoon D; Gilmore C; Farr G; Amatya R
    Contraception; 1998 Oct; 58(4):201-6. PubMed ID: 9865999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T.
    Andersson K; Batar I; Rybo G
    Contraception; 1992 Dec; 46(6):575-84. PubMed ID: 1493717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical performance of a new levonorgestrel-releasing intrauterine device. A randomized comparison with a nova-T-copper device.
    Nilsson CG; Luukkainen T; Diaz J; Allonen H
    Contraception; 1982 Apr; 25(4):345-56. PubMed ID: 6809420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized clinical trial with intrauterine devices (levonorgestrel intrauterine device (LNG), CuT 380Ag, CuT 220C and CuT 200B). A 36-month study. Indian Council of Medical Research Task Force on IUD.
    Baveja R; Bichille LK; Coyaji KJ; Engineer AD; Gogoi MP; Hazra MN; Kochhar M; Lahiri BC; Manuel M; Nanda UK
    Contraception; 1989 Jan; 39(1):37-52. PubMed ID: 2491981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levonorgestrel levels in serum and uterine flushings in women bearing LNG-Cu-IUD.
    Shi JP; Wu XR
    J Tongji Med Univ; 1993; 13(2):126-8. PubMed ID: 8230357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the clinical performance, contraceptive efficacy and acceptability of levonorgestrel-releasing IUD and Norplant-2 implants in China.
    Gao J; Wang SL; Wu SC; Sun BL; Allonen H; Luukkainen T
    Contraception; 1990 May; 41(5):485-94. PubMed ID: 2112079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B; Zeng T; Wu S; Sun H; Xiao N
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and acceptability of a low-dose levonorgestrel intravaginal ring for contraception in a UK cohort.
    Elder MG; Lawson JP; Elstein M; Nuttall ID
    Contraception; 1991 Feb; 43(2):129-37. PubMed ID: 1904020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of IUDs: a review.
    Sivin I; Schmidt F
    Contraception; 1987 Jul; 36(1):55-84. PubMed ID: 3311626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
    French R; Van Vliet H; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Helmerhorst F; Guillebaud J
    Cochrane Database Syst Rev; 2004; 2004(3):CD001776. PubMed ID: 15266453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NORPLANT and the levonorgestrel IUD in Chinese family planning programmes.
    Xiao BL; Gu SJ; Wang SL; Zhu PD; Shi SQ
    Ann Med; 1993 Apr; 25(2):161-5. PubMed ID: 8489754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five years private practice experience of nulliparous women using copper IUD's.
    Smith RP; Goresky DM; Etchell DM
    Contraception; 1980 Apr; 21(4):335-42. PubMed ID: 7389354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Copper T 220C: a new long-acting copper intrauterine contraceptive device.
    Cooper DL; Millen AK; Mishell DR
    Am J Obstet Gynecol; 1976 Jan; 124(2):121-4. PubMed ID: 1247047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The levonorgestrel-releasing intrauterine device.
    Toivonen J
    Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.